Indibulin - CISMeF

Preferred Label : Indibulin;

NCIt synonyms : D 24851; N-(Pyridin-4-yl)-(1-(4-chlorobenzyl)indol-3-yl)glycoxylamide;

NCIt definition : A synthetic small molecule with antimitotic and potential antineoplastic activities. Indibulin binds to a site on tubulin that is different from taxane- or Vinca alkaloid-binding sites, destabilizing tubulin polymerization and inducing tumor cell cycle arrest and apoptosis. This agent has been shown to be active against multidrug-resistant (MDR) and taxane- resistant tumor cell lines.;

UNII : 80K4H2RB8P;

InChIKey : SOLIIYNRSAWTSQ-UHFFFAOYSA-N;

CAS number : 204205-90-3;

Molecule name : D-24851; D 24851; ZIO-301;

Chemical formula : C22H16ClN3O2;

Détails

Origin ID

C2049;

UMLS CUI

C1956330;

Automatic exact mappings (from CISMeF team)
- D 24851 [MeSH concept]
- indibulin [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- indibulin [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- indibulin [MeSH Supplementary Concept]
- indibulin [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Microtubule Process [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients